Cargando…

Actions of L-Glutamine vs. COVID-19 Suggest Additional Benefit in Sickle Cell Disease

Background:The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection associated with coronavirus disease 2019 (COVID-19) causes a 3- to 9-fold higher age-adjusted mortality in African American and Hispanic populations, the major US racial groups affected by sickle cell disease (SCD)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdelaal, Mahmoud A.Z., Abdelrahman, Dyala, Cengiz, Mahir, Yavuzer, Hakan, Yavuzer, Serap, Bien, Ivy, Bhuva, Preeti, Pham, Jessica V, Siu, Royal, Tang, Mengdi, Ward, Ashley, Goodrow, Jason, Ludlum, Peter, Stark, Charles W., Perrine, Susan P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2020
Materias:	114.Hemoglobinopathies, Excluding Thalassemia-Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330293/ http://dx.doi.org/10.1182/blood-2020-135903

Ejemplares similares

Outcomes of Sickle Cell Disorders in COVID-19 Infection: An Institutional Experience
por: Sewaralthahab, Sarah, et al.
Publicado: (2020)

Hospitalization and Case Fatality in Individuals with Sickle Cell Disease and COVID-19 Infection
por: Mucalo, Lana, et al.
Publicado: (2020)

Impact of Sickle Cell Trait on Morbidity and Mortality from Sars-Cov-2 Infection
por: Merz, Lauren E., et al.
Publicado: (2020)

Healthcare Utilization Among Children and Adolescents with Sickle Cell Disease during the COVID-19 Pandemic
por: Nowlin, Andrea, et al.
Publicado: (2020)

Sickle Cell Disease Related Outcomes in Patients Evaluated for COVID-19 Infections in South Carolina
por: Noisette, Laurence, et al.
Publicado: (2020)

Venous Thromboembolism Prophylaxis Practices for Patients with Sickle Cell Disease Pre and during the COVID-19 Pandemic
por: Davila, Jennifer G., et al.
Publicado: (2020)

Identification of the Pitfalls in the Attempted Use of Extracorporeal Membrane Oxygenation in an Adult Patient with Sickle Cell Disease and Severe Acute Chest Syndrome
por: Tanenbaum, Mira T, et al.
Publicado: (2019)

Thrombosis and Risk Management in Paediatric Inflammatory Multisystem Syndrome - Temporally Associated with Sars-CoV2 (PIMS-TS)
por: Lam, Ho Pui Jeff, et al.
Publicado: (2020)

COVID-19 in Hospitalized Patients with Sickle Cell Disease
por: Guarino, Stephanie, et al.
Publicado: (2021)

COVID-19 Infection and Outcomes at a Comprehensive Sickle Cell Center
por: El Rassi, Fuad, et al.
Publicado: (2021)

Sickle Cell Disease and COVID-19 Infection: A Single-Center Experience
por: Devarashetty, Sindhu, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on Acute Care Visits for Patients with Sickle Cell Disease
por: Orkoulas-Razis, Dennis, et al.
Publicado: (2021)

Excess All-Cause Mortality in 2020 for People Living with Sickle Cell Disease in New York City
por: Curtis, Susanna A, et al.
Publicado: (2021)

Incidence of Sars-COV-2 Infection in Sickle Cell Patients Presenting with a Painful Crisis, a 12 Month Prospective Cohort Study
por: Konté, Kadère, et al.
Publicado: (2021)

Sickle Cell Disease (SCD) As a Risk for COVI19 Compared to Those without SCD Among Patients Admitted in a Large Urban Center, As Estimated By PCR Sars-v-2 Positive Vs Negative Testing
por: Adamkiewicz, Tom, et al.
Publicado: (2021)

Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic
por: Rao, Shivani, et al.
Publicado: (2021)

Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19
por: Rao, Shivani, et al.
Publicado: (2021)

Whole Blood Adhesion to VCAM-1 and P-Selectin and RBC Mechanical Fragility Can be Compromised in Long COVID-19 Patients with Sickle Cell Disease
por: Tarasev, Michael, et al.
Publicado: (2021)

Effect of oral l-Glutamine supplementation on Covid-19 treatment
por: Cengiz, Mahir, et al.
Publicado: (2020)

Sickle Cell Disease in Africa: A Neglected Cause of Early Childhood Mortality
por: Grosse, Scott D., et al.
Publicado: (2011)

Profiling Dose-Dependent Activation of p53-Mediated Signaling Pathways by Chemicals with Distinct Mechanisms of DNA Damage
por: Clewell, Rebecca A., et al.
Publicado: (2014)

Radiostereometric Evaluation of Tendon Elongation After Distal Biceps Repair
por: Marshall, Nathan E., et al.
Publicado: (2016)

Lateral Elbow Tendinopathy: Development of a Pathophysiology-Based Treatment Algorithm
por: Bhabra, Gev, et al.
Publicado: (2016)

Spanish Consensus Statement: Clinical Management and Treatment of Tendinopathies in Sport
por: Fernandez-Jaén, Tomas, et al.
Publicado: (2017)

Presentation, Management and Outcomes of COVID-19 Patients with Sickle Cell Disease
por: Anusim, Nwabundo, et al.
Publicado: (2020)

Hepatobiliary Manifistations of COVID-19 in Sickle Cell Disease: A Case Report
por: Alghamdi, Badria M., et al.
Publicado: (2020)

Drepadom - Home Care Services and Hospitalizations for Sickle Cell Disease Patients during the Covid-19 Pandemic
por: De Luna, Gonzalo, et al.
Publicado: (2020)

Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea
por: Allard, Pierre, et al.
Publicado: (2021)

Measurement of antibody levels in patients with COVID-19 over time by immunofluorescence assay: a longitudinal observational study
por: Uysal, Betul Borku, et al.
Publicado: (2022)

The impact of protein oxidation on sustained and white coat hypertension
por: Yıldırım, Erkan, et al.
Publicado: (2017)

Differential Expression of Hypertension-Associated MicroRNAs in the Plasma of Patients With White Coat Hypertension
por: Cengiz, Mahir, et al.
Publicado: (2015)

Case Report: A COVID-19 Patient Presenting with Mild Rhabdomyolysis
por: Borku Uysal, Betul, et al.
Publicado: (2020)

Circulating miR-21 levels in hypertensive patients with asymptomatic organ damage
por: Yildirim, Erkan, et al.
Publicado: (2019)

Immunothérapie dans le mélanome en hospitalisation à domicile : enquête de satisfaction et retour d’expérience des centres français d’oncodermatologie
por: Truong, Thao, et al.
Publicado: (2021)

Intérêt d’une dose unique de Tocilizumab 400 mg sur les formes sévères d’infection respiratoire à COVID-19
por: Rossi, B., et al.
Publicado: (2020)

COVID-19 seroconversion in the aircrew from Turkey
por: Islamoglu, Mehmet Sami, et al.
Publicado: (2021)

Outcomes of cavotricuspid isthmus-dependent fLutter ablation: randomized study comparing single vs multiple catheter procedures. The SIMPLE study
por: Falasconi, G, et al.
Publicado: (2023)

Cryoablation of atrioventricular nodal reentry tachycardia with utilization of three-dimensional electroanatomic mapping system
por: Podlogar, V, et al.
Publicado: (2023)

Impact of 3-dimensional electroanatomic mapping systems on fluoroscopy reduction in catheter ablation of supraventricular tachycardia - then and now
por: Chua, Y Y, et al.
Publicado: (2023)

Spontaneous left-sided atypical flutter: revising the mechanisms in patients not submitted to prior linear ablation
por: Brito, J, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7p13up3qrc06mfncmi8co7u2qs